A detailed history of Richelieu Gestion PLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Richelieu Gestion PLC holds 929 shares of LLY stock, worth $737,756. This represents 0.74% of its overall portfolio holdings.

Number of Shares
929
Previous 582 59.62%
Holding current value
$737,756
Previous $339,000 113.27%
% of portfolio
0.74%
Previous 0.3%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

BUY
$592.2 - $792.28 $205,493 - $274,921
347 Added 59.62%
929 $723,000
Q4 2023

Jan 16, 2024

BUY
$525.19 - $619.13 $174,363 - $205,551
332 Added 132.8%
582 $339,000
Q3 2023

Oct 18, 2023

BUY
$434.7 - $599.3 $108,675 - $149,825
250 New
250 $134,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Richelieu Gestion PLC Portfolio

Follow Richelieu Gestion PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Richelieu Gestion PLC, based on Form 13F filings with the SEC.

News

Stay updated on Richelieu Gestion PLC with notifications on news.